BMJ Publishing Group, BMJ, 7565(333), p. 420-0, 2006
DOI: 10.1136/bmj.38902.605347.7c
Full text: Download
Objective: To investigate the potential beneficial and adverse effects of frusemide to prevent or treat acute renal failure in adults. Design: Meta-analysis of randomised controlled trials. Data sources: Cochrane controlled trials register (2005 issue 4), Embase, and Medline (1966 to 1 February 2006), without language restrictions. Review methods: Two reviewers checked the quality of the studies and independently extracted data. Results: Nine randomised controlled trials totalling 849 patients with or at risk of acute renal failure were included. Outcome measures not significantly different after frusemide treatment were in-hospital mortality (relative risk 1.11, 95% confidence interval 0.92 to 1.33), risk for requiring renal replacement therapy or dialysis (0.99, 0.80 to 1.22), number of dialysis sessions required (weight mean difference - 0.48 sessions, - 1.45 to 0.50), and proportion of patients with persistent oliguria (urine output